Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Jul 05, 2021 1:30pm
118 Views
Post# 33493308

RE:July Presentation

RE:July PresentationEbbFlow88,

The functional drink in the pipeline graph was in the May presentation, but disappeared in the June presentation.  

My guess is that "advanced discussions" didn't go anywhere wrt an oat BG carrier in a functional drink due to economics and now we need to see how efficacy plays out on Y-BG and sodium alginate BG. So for accuracy they removed it as it is replaced by the alternate carriers in pre-clinical studies.

Maybe a Mickey Mouse functional drink deal version 1 could have been done but customer(s) are just waiting for version 2 with the alternate carriers.

I don't know if there is a sense of urgency in getting a functional drink (or food) deal. It's been in the works for 2-3 years now. Perhaps they can fast track clinical studies with the alternate carriers.

<< Previous
Bullboard Posts
Next >>